Connect with us

Health

Nigeria, Others to Receive 220 million J&J Vaccine Doses

Published

on

Johnson Johnson vaccine

By Adedapo Adesanya

Nigeria and the other 54-member states of the African Union (AU) will receive the supply of up to 220 million doses of the Johnson & Johnson single-shot vaccine by the end of 2022.

The expected delivery of the J&J vaccine doses followed an agreement signed by the United Nations Children Fund (UNICEF) with Janssen Pharmaceutica NV, which will see some 35 million doses delivered by the end of this year, UNICEF stated in a statement issued in New York.

The agreement between UNICEF and Janssen Pharmaceutica NV will help implement the Advance Purchase Commitment (APC) signed between the African Vaccine Acquisition Trust (AVAT) and Janssen last March.

That agreement secured an option to order another 180 million doses, bringing the maximum access up to a total of 400 million doses by the end of 2022.

The AU established AVAT in November 2020 to deliver COVID-19 vaccines to the African continent, with a goal of vaccinating 60 per cent of the population of member-states.

Under the plan, the African Export-Import Bank (Afreximbank) and AVAT have signed a cooperation agreement on behalf of the AU for the development of an Advance Procurement Commitment (APC) Framework to support member-states access to COVID-19 vaccines.

UNICEF will procure and deliver COVID-19 vaccines on behalf of the AVAT initiative.

Other partners include the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Bank while multiple vaccines are anticipated to be part of the initiative’s portfolio, Janssen’s single-dose vaccine is the first to be included.

“African countries must have affordable and equitable access to COVID-19 vaccines as soon as possible.

“Vaccine access has been unequal and unfair, with less than one per cent of the population of the African continent currently vaccinated against COVID-19 and this cannot continue,” a part of the statement said.

UNICEF Executive Director, Ms Henrietta Fore, further stated that, “UNICEF, with its long history of delivering vaccines all around the world, is supporting global COVID-19 vaccination efforts through AVAT, COVAX, and other channels to maximize supply and access to vaccines.”

Drawing upon decades of experience as the largest single vaccine buyer in the world as it does annually for routine immunization, UNICEF is acting as a procurement and logistics agency on behalf of the AVAT partnership.

UNICEF says it stands ready to facilitate the procurement, transport and delivery of vaccines as soon as they become available and AU member-states are ready to receive them.

UNICEF plans to work with the vaccine industry, freight forwarders and transport companies to get the doses to the communities that need them.

Janssen’s COVID-19 vaccine received a World Health Organisation (WHO) Emergency Use Listing (EUL) on March 12 and is relying on a global supply network to produce the vaccine.

The latest site for production, Aspen Pharmacare in Gqeberha, South Africa, was approved by the WHO in June.

The delivery of the vaccine is expected to begin later in the third quarter of 2021, with allocations to be determined by the Africa Centre for Disease Control (ACDC).

The agreement comes as the African continent faces the steepest surge in COVID-19 cases yet and vaccine supply challenges have left many countries with large unvaccinated populations.

In addition to its role in this partnership, UNICEF is also a key implementing partner for the COVAX Facility led by Gavi, the Vaccine Alliance, WHO, and CEPI.

Under this initiative, UNICEF has contributed to the delivery of more than 100 million doses to 135 countries.

UNICEF’s role in procuring and delivering COVID-19 vaccines on behalf of AVAT will complement and supplement the shared COVAX goal of ensuring equitable access to quality-assured COVID-19 vaccines.

“Vaccinating the world against COVID-19, as the virus continues to spread and mutate, is one of the largest and most complex collective health undertakings the world has ever seen, and we need all hands on deck.

“In the race to defeat this virus, equity is not a ‘nice to have’ — it’s an absolute necessity. This pandemic has cost everyone something, and some people everything.

“Only together can we bring the suffering to an end,” the statement added.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Malaria: SUNU Health Advocates Wider Adoption of HMO Plans

Published

on

SUNU Health --logo

By Aduragbemi Omiyale

To achieve a malaria-free Nigeria, a leading Health Maintenance Organisation (HMO) with a robust nationwide presence, SUNU Health Nigeria Limited, has called for a wider adoption of HMO packages for citizens.

It stressed that managed care provides a critical safety net, ensuring families can access quality preventive services without the burden of immediate, high costs, adding that this structured approach transforms healthcare from an unpredictable expense into a manageable, guaranteed service.

The company, which officially unveiled a comprehensive strategic roadmap aimed at drastically cutting down on malaria-related deaths, emphasised that the disease can be eradicated if citizens and stakeholders adopt consistent preventive measures.

“Eradication is within our reach if we synchronise our efforts,” the chief operating officer of SUNU Health, Dr Faith Nwachi, said, noting that the tools for victory range from environmental hygiene to the consistent use of treated nets, which are easily accessible to every Nigerian.

The organisation noted that it came up with the latest framework to significantly reduce the disease burden that has historically hindered Nigeria’s productivity and public health stability.

The urgency of this intervention is underscored by concerning data from late 2025, which revealed a sharp upward trend in cases, it stated.

With over 24.5 million confirmed cases reported in the first nine months of last year alone, the 2026 landscape demands aggressive action. Currently, malaria remains a leading cause of mortality, responsible for approximately 30 per cent of child deaths and 11 per cent of maternal deaths annually.

A central pillar of the roadmap is a focus on preventative care. As of early 2026, according to the World Health Organisation, malaria still accounts for nearly 30 per cent of all hospital admissions in Nigeria.

By addressing the root causes and transmission cycles, SUNU Health seeks to drastically lower these statistics, ensuring Nigerians can lead more active lives without the constant threat of infection.

Dr Nwachi further underscored the economic necessity of this shift, stating that “prevention is significantly cheaper than cure.”

The financial toll on the Nigerian economy is staggering, with billions of Naira lost annually to treatments and diminished man-hours. For the average family, frequent bouts of illness lead to catastrophic out-of-pocket expenses that undermine financial security.

Continue Reading

Health

AltBank, Partners Recommend Autism Care Financing Options, Others to Government

Published

on

Autism Care Financing Options

By Aduragbemi Omiyale

Plans are underway by the Alternative Bank (AltBank) to present a policy brief to relevant government ministries, recommending vocational pathways, autism care financing options, and a 12-month Lagos pilot across selected schools and primary healthcare centres.

The recommendations are from the inaugural Autism Stakeholders Roundtable and Policy Dialogue in Lagos, organised by the lender in partnership with the Private Sector Health Alliance of Nigeria (PSHAN), Eliakim Foundation, and Sterling One Foundation under the theme, It is How You Show Up.

The programme served as a critical platform to address the country’s fragmented autism support systems, with leading healthcare professionals, policymakers, and autism advocates in attendance, praising the financial institution’s decisive shift toward early intervention, systemic inclusion, and comprehensive capacity building for parents and caregivers.

The president of the Medical Women’s Association of Nigeria (MWAN) Lagos State Branch, Dr Ime Okon, stressed her group’s alignment with the bank’s initiatives.

“We recognise caregivers and families as central to the success of any intervention. We are showing up, holding their hands, to ensure they are never left to navigate this journey alone.

“For a physician, showing up means ensuring that a parent’s first concern is met with a strengthened, inclusive system rather than a clinical dead-end with no solution. The Alternative Bank has signalled a shift toward a high-level platform for national action,” she stated.

Validating this urgent need for systemic early response, the keynote speaker and founder of the Patrick Speech and Languages Centre (PSLC), Mrs Dotun Akande, advocated the integration of universal developmental screening into primary healthcare, stressing that Nigeria must transition from relying on parallel private centres to building a coordinated national response.

“What Nigeria must now build is a system where intervention happens early, equitably, and at scale, without depending on chance, geography, or privilege,” Mrs Akande noted, outlining the necessity of a caregiver support scheme that addresses both the financial and social needs of families navigating autism.

Answering this call to action, the Executive Director of Commercial and Institutional Banking (Lagos and Southwest) at The Alternative Bank, Mrs Korede Demola-Adeniyi, unveiled the financial institution’s concrete commitments to parent and professional training.

Noting that showing up in Nigeria has “too often meant showing up late,” she announced a robust three-pillar intervention agenda focusing on inclusive education, targeted training for caregivers and health professionals, and behavioural change advocacy.

As an immediate first step, Mrs Demola-Adeniyi announced the launch of a specialised capacity-building programme on Receptive Language Disorder, executed in collaboration with Eliakim Global Resources, which commenced on Sunday, April 26, 2026.

“Early recognition and sustained support depend on a workforce and caregivers who know what to look for, and what to do next,” she explained, emphasising that receptive language is a consequential developmental marker that is frequently missed.

The roundtable fostered dynamic discussions on practically designing and sustainably funding high-impact support programmes.

Continue Reading

Health

Court Okays FCCPC to Regulate Consumer Protection in Healthcare

Published

on

Go to court

By Adedapo Adesanya

The Abuja division of the Federal High Court has delivered a landmark ruling reinforcing consumer protection in Nigeria’s healthcare sector, affirming the authority of the Federal Competition and Consumer Protection Commission (FCCPC) to investigate complaints related to medical services, including alleged negligence.

Justice Emeka Nwite, who presided over the matter, delivered the judgment on April 15 in a suit filed by Life Bridge Medical Diagnostic Centre Ltd.

The company had challenged the FCCPC’s jurisdiction, arguing that the commission could not probe medical negligence cases without first establishing a formal arrangement with the Medical and Dental Council of Nigeria (MDCN).

However, the court dismissed the claims, holding that healthcare providers operating as commercial entities fall squarely under the provisions of the Federal Competition and Consumer Protection Act (FCCPA).

Justice Nwite ruled that services rendered for value, including medical diagnostics, are subject to consumer protection oversight.

In the decisive clarification, the court drew a line between professional regulation and consumer protection. It said that while disciplinary control of medical practitioners remains the responsibility of professional bodies such as the MDCN, the FCCPC retains authority over issues of service quality, fairness, and consumer satisfaction.

The court further held that Section 105 of the FCCPA, which encourages regulatory coordination, does not limit or delay the FCCPC’s statutory powers.

According to the ruling, the absence of a formal agreement with sector regulators does not invalidate the Commission’s authority to act.

Justice Nwite also addressed concerns around patient confidentiality, ruling that ethical obligations do not override lawful investigations carried out in the public interest and in compliance with due process.

Reacting to the judgment, FCCPC executive vice chairman, Tunji Bello, described the decision as a major step toward strengthening consumer rights across all service sectors.

He emphasised that the ruling underscores the principle that consumer protection and professional regulation can coexist without conflict.

Continue Reading

Trending